Alastair Garfield
Chief Scientific Officer · 2 filings · Latest: Feb 11, 2026
RHYTHM PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RYTM | Alastair Garfield | Chief Scientific Officer | Feb 1, 2026 | Option Exercise | — | 6,663 | — | 9,789 |